These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


724 related items for PubMed ID: 17077357

  • 1. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1546-57. PubMed ID: 17077357
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ, Jang JH, Tang N, Deng H, Head R, Bell JC, Stojdl DF, Nutt CL, Senger DL, Forsyth PA, McCart JA.
    Clin Cancer Res; 2009 Apr 15; 15(8):2777-88. PubMed ID: 19351762
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M, Cramer SD, Lyles DS.
    Virology; 2004 Dec 05; 330(1):34-49. PubMed ID: 15527832
    [Abstract] [Full Text] [Related]

  • 4. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.
    Cancer Res; 2003 May 15; 63(10):2462-9. PubMed ID: 12750267
    [Abstract] [Full Text] [Related]

  • 5. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
    Wei J, Wahl J, Nakamura T, Stiller D, Mertens T, Debatin KM, Beltinger C.
    Gene Ther; 2007 Nov 15; 14(22):1573-86. PubMed ID: 17898797
    [Abstract] [Full Text] [Related]

  • 6. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
    Ebert O, Harbaran S, Shinozaki K, Woo SL.
    Cancer Gene Ther; 2005 Apr 15; 12(4):350-8. PubMed ID: 15565179
    [Abstract] [Full Text] [Related]

  • 7. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H, Aoki H, Kühnel F, Kondo Y, Kubicka S, Wirth T, Iwado E, Iwamaru A, Fujiwara K, Hess KR, Lang FF, Sawaya R, Kondo S.
    J Natl Cancer Inst; 2006 May 03; 98(9):625-36. PubMed ID: 16670388
    [Abstract] [Full Text] [Related]

  • 8. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.
    Clin Cancer Res; 2007 Dec 01; 13(23):7155-65. PubMed ID: 18056196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN, Kang CY.
    Virology; 2007 Jan 05; 357(1):41-53. PubMed ID: 16962155
    [Abstract] [Full Text] [Related]

  • 12. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC, Zhang T, Fukuhara H, Kuroda T, Todo T, Canron X, Bikfalvi A, Martuza RL, Kurtz A, Rabkin SD.
    Clin Cancer Res; 2006 Nov 15; 12(22):6791-9. PubMed ID: 17121900
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.
    Neurosurgery; 2009 Sep 15; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J, Frolov I, Russell SJ.
    J Gene Med; 2004 Oct 15; 6(10):1082-91. PubMed ID: 15368589
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of vesicular stomatitis virus matrix protein on proliferation and apoptosis of mouse LL/2c cells].
    Zhao JM, Liu T, Xu JR, Wang GQ, Du XB, Wen YJ.
    Ai Zheng; 2007 Mar 15; 26(3):230-5. PubMed ID: 17355782
    [Abstract] [Full Text] [Related]

  • 19. Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.
    Wu Y, Lun X, Zhou H, Wang L, Sun B, Bell JC, Barrett JW, McFadden G, Biegel JA, Senger DL, Forsyth PA.
    Clin Cancer Res; 2008 Feb 15; 14(4):1218-27. PubMed ID: 18281557
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.